Navigation Links
C5 Medical Werks Reaches Million Mark in Components Shipped
Date:7/29/2008

Global provider of ceramic implantable components surpasses projected

goals.

DENVER, July 29 /PRNewswire/ -- C5 Medical Werks, a manufacturer of high-quality ceramic solutions for the medical device industry, announced today that, in June 2008, the Company shipped its one millionth ceramic implantable component based on unit shipments to the orthopaedic, brachytherapy and electro-implantable market segments.

The Company's state-of-the-art facility, located in Grand Junction, Colo., produces ceramic components and assemblies for hip and knee joints, motion preservation/total disc replacement components used in spine surgery, as well as seeds for brachytherapy. Additional medical grade ceramic implantables include crowns, bridges, abutments and implants for dental applications and electro-implantable devices such as cochlear implants, neuro-stimulators and neuro-sensors.

Combining a medical grade quality system and advanced technical expertise with a customer-centric business philosophy, C5 Medical Werks is recognized as a leading supplier of ceramic components to the medical device industry.

"Reaching this level of productivity in 2008, places us in an excellent position to capitalize on continued growth in the orthopaedic, spinal, dental and custom ceramic component markets we serve worldwide," said Andrew Nield, Director of Sales and Marketing for C5 Medical Werks. "In addition, our extensive knowledge of ceramic materials allows us to quickly respond to the needs of our customers."

About C5 Medical Werks

C5 Medical Werks is a wholly owned subsidiary of CoorsTek, the largest manufacturer of technical ceramics in North America, and is a leading provider of ceramic solutions for the medical device industry. The Company manufactures medical grade components with an emphasis on ceramic materials. Based in the United States, the company operates an FDA registered, state-of-the-art facility with a single, comprehensive quality system certified to ISO 13485:2003, compliant with FDA's Quality System Regulation (21 CFR 820) and meeting all other applicable governmental requirements. Product lines include ceramic implantable components to be used in orthopaedic spine and dental applications, as well as other custom implant components. C5 Medical Werks excels at manufacturing premium implantable components that help people live better lives.

C5 Medical Werks is located at 2451 River Road, Grand Junction, CO 81505. For more information, please visit http://www.c5medicalwerks.com or call (877) 259-3757.


'/>"/>
SOURCE C5 Medical Werks
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Georgetown Medical Center collaborates to develop cancer research database
2. Southern Home Medicals Encore Medical Staffing Division Poised to Benefit from Major Growth in Nursing Industry
3. InfoLogix Selected by University Medical Center to Deploy Mobile Wireless Asset Tracking Solution
4. Partnership Improves Medical Records Management within Corrections Facilities
5. Palomar Medical Technologies to Host Second Quarter 2008 Financial Results Conference Call and Webcast on July 31, 2008
6. New $4.2m UQ medical center to boost rural doctor numbers
7. Connecticut State Medical Society Chooses gloStream as a Preferred Electronic Medical Record and Practice Management Solutions Provider
8. SeQual Technologies, American Lung Association of California and Seton Medical Center Partner to Support Survivor & Cyclist in 500-Mile California Ride
9. China Medical Technologies to Announce Financial Results for the First Quarter Ended June 30, 2008 on August 4, 2008
10. Aging Baby Boomers Meld Life-saving Data and Style with Lauren's Hope Fashion Medical ID Bracelet
11. Hurricane preparedness survey: Worries about drinking water and medical care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... ... September 25, 2017 , ... SyncDog, Inc., ... of SentinelSecure™, version 3.0, will be available in a managed cloud services model, ... SentinelSecure™ comes with several new enhancements including support for caller ID and network ...
(Date:9/25/2017)... ... 2017 , ... Nissar A. Darmani, PhD, has been awarded a record WesternU ... nausea and vomiting. Dr. Darmani is Associate Dean of Basic Medical Sciences in ... is from the National Cancer Institute (NCI) arm of the National Institutes of Health ...
(Date:9/25/2017)... ... September 25, 2017 , ... Just ask anyone old enough to remember what ... headgear so wired up and containing so much metal that jokes about radio reception ... its treatments can barely be observed. As a result, it’s now a billion-dollar industry ...
(Date:9/25/2017)... ... September 25, 2017 , ... Winners in ... announced on Friday, September 22 during a gala event in New York City. ... achievements and HR-related products and suppliers who help to create and drive great ...
(Date:9/25/2017)... ... September 25, 2017 , ... How many things are on your average daily ... “more than any sane human could possibly complete,” then you’re all too familiar with ... desperately trying to be everything to everybody all the time. , Self-proclaimed overly productive ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... BOTHELL, Wash. , Sept. 7, 2017   BioLife ... developer, manufacturer and marketer of proprietary clinical grade cell and ... media ("BioLife"), announces that Mike Rice , President and ... Rodman & Renshaw 19 th ... 3:25 p.m. Eastern time (12:25 p.m. Pacific time). The conference ...
(Date:9/6/2017)... -- Eli Lilly and Company (NYSE: LLY ... galcanezumab and lasmiditan, two investigational treatments for migraine, at ... taking place Sept. 7-10 in Vancouver ... data from an open-label study evaluating the safety and ... 240 mg) for the prevention of migraine. Galcanezumab is ...
(Date:9/5/2017)... , Sept. 5, 2017 Oramed Pharmaceuticals Inc. ... ), a clinical-stage pharmaceutical company focused on the development ... has successfully concluded its meeting with the U.S. Food ... oral insulin formulation. ... the regulatory pathway for submission of ORMD-0801, would be ...
Breaking Medicine Technology: